Physician profile
Kellye Moore-Texter
NPI 1891354247
$543.88
in general payments reported to CMS, 2019-2025
12 companies · $163 in 2025
The $163 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $59.45 · 2022: $145 · 2024: $177 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $340.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $339.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $93.50 | 2021-2024 | Axonics |
| Janssen Biotech, INC. | $90.00 | 2022 | |
| Abbvie INC. | $82.93 | 2024-2025 | |
| Urogen Pharma, INC. | $61.92 | 2024-2025 | |
| Tolmar, INC. | $48.20 | 2025 | Jatenzo |
| Medtronic, INC. | $35.55 | 2022 | |
| Dentsply Ih Ab | $34.35 | 2025 | Lofric |
| 180 Medical, INC. | $26.88 | 2024 | |
| Progenics Pharmaceuticals, INC. | $20.45 | 2024 | |
| Coloplast Corp | $18.77 | 2024 | |
| Sumitomo Pharma America, INC. | $17.16 | 2025 | Gemtesa |
| Amgen INC. | $14.17 | 2024 | Prolia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kellye Moore-Texter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.